My watch list
my.bionity.com  
Login  

Eurofins signs agreement to acquire Lancaster Laboratories, Inc.

28-Feb-2011

Eurofins Scientific SE has signed a definitive agreement to acquire Lancaster Laboratories, Inc. from Thermo Fisher Scientific, Inc. for approximately US$200m, subject to post-closing adjustments.

With approximately 1,100 employees in the USA and Ireland, Lancaster is a leading provider of pharmaceutical product testing services and cGMP Quality Control (QC) in North America. In addition, it operates one of the leading environmental testing laboratories in the USA.

With this bolt on acquisition, the Eurofins Group becomes the global leader in this very stable and recurring business and significantly enlarges its North American footprint. It is a further expression of Eurofins’ commitment to serve the pharmaceutical and biotechnology industries with laboratory services of the highest quality and reliability.

Completion of the transaction is expected in the next 2-3 months and is subject to applicable regulatory approvals and customary closing conditions. Implied EV/EBITDA multiple is in-line with levels previously communicated for transactions of this size and Eurofins’ value-creation objectives. Given that Lancaster is already a single-site laboratory in the USA, no site consolidations or restructuring costs are foreseen as a result of this acquisition. Based on Lancaster’s historic profitability and budget for 2011, the transaction should be immediately margin and EPS accretive for Eurofins.

Facts, background information, dossiers
More about Eurofins
  • News

    Zika virus test receives FDA emergency use authorization

    Viracor-IBT Laboratories Inc. (Viracor-IBT), a wholly-owned subsidiary of Eurofins Scientific (EUFI.PA), announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay. Viracor-IBT will perform this ass ... more

    Eurofins signs an exclusive agreement to acquire the Biomnis Group

    Eurofins Scientific announced that it has signed an exclusive agreement with Financière Bio Alfras SAS to acquire the Biomnis Group for approximately EUR 220m. The contemplated transaction is expected to be completed over the summer, subject to customary closing conditions including regulat ... more

    Eurofins acquires Diatherix Laboratories, Inc.

    Eurofins Scientific  announces that it has signed an agreement to acquire Diatherix Laboratories, Inc. for approximately US$ 50m, plus an earn-out upon achievement of pre-defined revenue and profitability targets. Completion of the transaction is expected in the next 30 days and is subject ... more

  • Companies

    Eurofins Medigenomix GmbH

    more

    Eurofins Genomics B.V.

    Eurofins Scientific is a life sciences company operating laboratories in 30 countries to provide a comprehensive range of analytical testing services drawing on the latest developments in biotechnology. The Group specialises in delivering analytical testing and advisory services to clients ... more

    Eurofins GfA Gesellschaft für Arbeitsplatz und Umweltanalytik mbH

    The Eurofins-GfA is accredited for more than 220 test procedures aq. DIN EN 45001. GfA supports industrial customers, authorities and scientific institutes with its main services being industrial emissions measurements and ambient air monitoring, workplace and indoor measurements, accidenta ... more

More about Lancaster Laboratories
  • News

    Eurofins signs agreement to acquire Lancaster Laboratories, Inc.

    Eurofins Scientific SE has signed a definitive agreement to acquire Lancaster Laboratories, Inc. from Thermo Fisher Scientific, Inc. for approximately US$200m, subject to post-closing adjustments. With approximately 1,100 employees in the USA and Ireland, Lancaster is a leading provider ... more

More about Thermo Fisher Scientific
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE